New Funding Dean's List

Notable & novel scientific awards to celebrate. All New Funding Awards can be viewed here

2018: July, August, September, October, November & December
2019: January, February, March, April

APRIL 2019

Competitive Renewals

Robert Mullins & Budd Tucker  •  Opthalmology & Visual Sciences
Choriocapillaris Protection and Replacement in AMD
NIH R01  •  4 years

Michael Shy  •  Neurology
The Inherited Neuropathy Consortium
Charcot-Marie-Tooth Association

New Federal Awards

Josalyn Cho  •  Internal Medicine
Airway Dendritic Cells in the Allergic Asthma Phenotype
NIH UH2  •  2 years

Kathleen Sluka  •  Physcial Therapy & Rehabilitation Sciences
Role of macrophages in activity-induced pan and analgesia
NIH R01  •  5 years

Marin Schweizer  •  Internal Medicine
Povidone-iodine to Stop Access-related Infections Transmission of Staphylococcus aureus (PAINTS)
AHRQ R01  •  5 years

Other Awards

Carlos Vigil Gonzalez  •  Internal Medicine
CPI-613 in Combination with High Dose Cytarabine and Mitoxantrone (CHAM) Compared to High Dose Cytarabine and Mitoxantrone (HAM) in Older Patients
Rafael Pharmaceuticals, Inc.

Matthew Howard  •  Neurosurgery
Neuronal Substrates of Hemodynamic Signals in the Prefrontal Cortex
California Institute of Technology

Dominique Limoli  •  Microbiology & Immunology
Michael Welsh  •  Internal Medicine

Modulating interspecies interactions in cystic fibrosis respiratory disease
Cystic Fibrosis Foundation

Michael Tomasson  •  Internal Medicine
Idasanutlin in Combination with Cytarabine and Daunorubicin in Patients Newly Diagnosed with AML and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission
Hoffmann-La Roche, Inc.

Yousef Zakharia  •  Internal Medicine
A Phase I Study of ASP1951 in Subjects with Advanced Solid Tumors
Astellas Pharma Global Development

 

MARCH 2019

Competitive Renewals

Robert Cornell  •  Anatomy & Cell Biology
Dissecting the transcriptional network governing differentiation of periderm
NIH R01  •  5 years

Chou-Long Huang  •  Internal Medicine
Klotho and Chronic Kidney Disease
NIH R01  •  5 years

Andrew Russo  •  Molecular Physiology & Biophysics
Perivascular mechanisms of CGRP-induced migraine symptoms
NIH R01  •  5 years

New Federal Awards

Alicia Gerke  •  Internal Medicine
Biomarkers for Severity, Therapy, and Disparity in Sarcoidosis: Discovery to Delivery
NIH R13  •  1 year

David Hasan  •  Neurosurgery
15-PGDH as a better therapeutic taret than aspirin in decreasing risk of intracranial aneurysm rupture in men and women equally
NIH R01  •  5 years

Elizabeth Newell  •  Pediatrics
Astrocyte-specific IL-1RL signaling effects following traumatic brain injury
NIH K08  •  5 years

Kalpaj Parekh  •  Surgery
Pathogenesis of Airway Stem Cell Abnormalities on Obliterative Bronchiolitis
NIH R01  •  5 years

Maria Spies  •  Biochemistry
Assembly and Dynamics of Molecular Machines in Genome Maintenance
NIH R35  •  5 years

Maria Spies  •  Biochemistry
Modulating Cancer Genetics for Immune Regulation and Breast Cancer Therapy
US Department of Defense, CDMRP  •  3 years

Maria Spies  •  Biochemistry
The role of human RAD52 protein in genome stability
NIH R01  •  5 years

Other Awards

Steven Polyak  •  Internal Medicine
The Efficacy and Safety of Upadacitinab (ABT-494) in Subjects with Moderately to Severely Active Ulcerative Colitis
AbbVie, Inc.

Katie Larson Ode  •  Pediatrics
EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis
Cystic Fibrosis Foundation

Michael Graham  •  Radiology
ImaginAb Clinical Trial
ImaginAb, Inc.

Randy Loftus  •  Anesthesia
The Attenuation of Intraoperative S. aureus Transmission and SSIs via Use of Indigo-Clean
Kenall Manufacturing

Christopher Nancy  •  Neurology
NeuroNext Clinical Trial - The TopCSPN Study/Topiramate as a Disease Modifying Therapy for CSPN
Massachusetts General Hospital

Helena Kenny  •  Internal Medicine
OPA1 KO Causes Cardiac Dysfunction, ER Stress and Heart Failure
MyoKardia, Inc

Stefan Strack  •  Pharmacology
Generation and characterization of mouse models of Jordan's Syndrome
Regents of the University of California, Davis

Loreen Herwaldt  •  Internal Medicine
Epicenters for the Prevention of Healthcare-Associated Infections (HAIs); Cycle II Multicenter Program Studies
University of Illinois at Chicago

 

FEBRUARY 2019

Competitive Renewals

Kim Leslie  •  Obstetrics & Gynecology
Targeted Therapy for Endometrial Cancer
NIH R01  •  5 years

New Federal Awards

Corinne Griguer  •  Radiation Research Lab
Paracrine Signaling in Glioma: Bioenergetics Heterogeneity and Chemoresistance
NIH R21  •  1 year

Balaji Manicassamy  •  Microbiology & Immunology
Endothelial Cell Tropism in the Pathogenesis and Host Response against Influenza Viruses
NIH R01  •  4 years

Other Awards

Nicholas Mohr  •  Emergency Medicine
Evaluating the Role of Telemedicine in Improving Rural Emergency Department Sepsis Care
ABHRQ K08

Mohammed Milhem  •  Internal Medicine
AST-008-102: A Phase 1b/2 Study of AST-008 Combined with Pembrolizumab in Patients with Advanced Solid Tumors
Exicure, Inc.

Mohammed Milhem  •  Internal Medicine
A Phase 1b/2 Study of FT-2102 in Patients with Advanced Solid Tumors and Gliomas with an IDH1 Mutation
Format Therapeutics, Inc.

Mohammed Milhem  •  Internal Medicine
A Phase 1/2, Open-label, Multicenter, Dose Escalation and Dose Expansion Study of NKTR-262 in Combination with NKTR-214 plus Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumor Malignancies
Nektar Therapeutics

Michael O'Donnell  •  Urology
A Multicenter, Single-Arm Study Evaluating the Efficacy of Synergo Radiofrequency-Induced Thermochemotherapy Effect (RITE) with Mitomycin C (Synergo RITE + MMC) in CIS Non-Muscle Invasive Bladder Cancer (NMIBC)
Medical Enterprises Europe B.V.

Yehudith Assouline-Dayan  •  Internal Medicine
A Phase 3, Randomized, 3-Part Study to Investigate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients with Eosinophilic Esophagitis
Regeneron Pharmaceuticals, Inc.

 

JANUARY 2019

Competitive Renewals

Kelly Falls  •  Radiation Research Laboratory
Targeting lung and breast cancer cell oxidative metabolism with D-penicillamine and disulfiram
NIH F30  •  2 years

George Weiner  •  Holden Comprehensive Cancer Center
Institutional Research Grant
American Cancer Society

New Federal Awards

Ryan Boudreau  •  Internal Medicine
Regulation and role of the cardiac sodium channel Nav1.5 in heart failure
NIH R01  •  5 years

John Fingert  •  Ophthalmology & Visual Sciences
Michael Anderson  •  Molecular Physiology & Biophysics

CRISPR/CAs9 approaches to model exfoliation syndrome
NIH R21  •  2 years

Dao-Fu Dai  •  Pathology
The role of energy sensor signaling in mitochondrial cardiomyopathy
NIH K08  •  5 years

Corinne Griguer  •  Radiation Research Laboratory
Cytochrome C Oxidase: Biomarker in Newly Diagnosed Glioblastomas Multiforme
NIH U01  •  2 years

Denise Hodgson-Zingman  •  Internal Medicine
A New Pacing Approach for Cardioprotection and Repair In Heart Failure
NIH R21  •  2 years

Alejandro Pezzulo  •  Internal Medicine
Heat-shock protein 90 modulates goblet cell metaplasma in human airway epithelia
NIH K01  •  5 years

Mark Santillan  •  Obstetrics & Gynecology
Vasopressin and Preeclampsia: Early Mechanisms for Prevention
NIH R01  •  5 years

Budd Tucker  •  Ophthalmology & Visual Sciences
Robert Mullins •  Ophthalmology & Visual Sciences

Molecular Basis of Complement Defense in Choroidal Endothelial Cells
NIH R21  •  2 years

Other Awards

Michael Tansey  •  Pediatrics
Evolucumab for Low Density Lipoprotein-Cholesterol (LDL-C) Reduction, as Add-On to Diet and Lipid-Lowering Therapy, in Pediatric Subjects 10 to 17 Years of Age with Heterozygous Familial Hypercholesterolemia (HeFH)
Amgen, Inc.

Eric Taylor  •  Biochemistry
Metabolomic Mechanisms of Action in the Mitochondrial Pyruvate Carrier Modulator MSDC-0602K
Cirius Therapeutics, Inc.

Yousef Zakharia  •  Internal Medicine
Proof of concept for lenvatinib and reverolimus prior to cytoreductive nephrectomy in eligible patients with locally advanced metastatic renal cell carcinoma (RCC)
Eisai, Inc.

Yousef Zakharia  •  Internal Medicine
Combination of Axitinib and Selenium in the Chemical Composition of Selenomethione (SLM) for adult patients with advanced metastatic clear cell renal cell carcinoma (CCRCC)
Pfizer, Inc.

Rohan Garje  •  Internal Medicine
Study of 177Lu-PSMA-617 in the Treatment of Patients with Progressive PSMA-Positive Metastatic Castration-Resistance Prostate Cancer
Endocyte, Inc.

John Bernat  •  Pediatrics
Long-Term Safety and Efficacy of Pegunigalsidase Alfa (PRX-102) 2 mg/kg Administered by Intravenous Infusion Every 4 Weeks in Patients with Fabry Disease
Protalix Biotherapeutics

John Engelhardt  •  Anatomy & Cell Biology
Statement of Work
Talee Bio, Inc.

Andrea Swenson  •  Neurology
Arimoclomol in Amyotrophic Lateral Sclerosis
Worldwide Clinical Trials, Inc.

 

NOVEMBER & DECEMBER 2018

Competitive Renewals

John Harty  •  Microbiology & Immunology
T resident memory in the lung
NIH R01  •  5 years

Denise Martinez  •  Medicine Administration
Summer Health Professions Education Program
Robert Wood Johnson Foundation

New Federal Awards

Anil Chauhan  •  Internal Medicine
Novel Therapeutic Intervention to Treat Ischemic Stroke
NIH R01  •  5 years

James Davis  •  Pediatrics
Fungal and Host Factors in Initiation of Cryptococcal Persistence
NIH K08  •  4 years

Krystal Parker  •  Psychiatry
Cerebellar circuits, timing, and cognition
NIH R01  •  5 years

David Weiss  •  Microbiology & Immunology
REU Site: Microbiology at The University of Iowa
NSF  •  3 years

Other Awards

Matthew Howard  •  Neurosurgery
Casual mapping of emotion networks with concurrent electrical stimulation of fMRI
California Institute of Technology

C. Michael Knudson  •  Tissue Procurement Core
TPC NDI PDX
Leidos, Inc.

Richard Smith & Carla Nester  •  Otolaryngology
C3 Glomerulopathy - A Longitudinal and Disovery Study
Novartis Corporation

Doug Laux  •  Internal Medicine
A randomized, open-label, multicenter, phase 1b/2 trial evaluating the safety and efficacy of intratumorally-administered ilixadencel in combination with CPI
Immunicum AB

John Bernat  •  Pediatrics
A Randomized, Double blind, Active Control Study of the Safety and Efficacy of PRX-102 to Agalside Beta on Renal Function in patients with Fabry Disease previously treated with Agalsidase Beta
Protalix Biotherapeutics

 

OCTOBER 2018

New Federal Awards

Ted Abel  •  Physiology & Biophysics
Molecular, Cellular and Circuit Effects of Sleep Deprivation on Hippocampus Function
NIH R01  •  5 years

Donna Hammond  •  Anesthesia
Nicotinamide Riboside for Relief of Taxane-Induced Sensory Neuropathy
NIH R21  •  2 years

Alison Lynch  •  Psychiatry
Collaborative Medication Assisted Treatment in Iowa 
SAMHSA H79  •  3 years

Frida Teran  •  Neurology
A novel dietary therapy for epilepsy: potential mechanisms of action
NIH F31  •  4 years

Aliye Uc  •  Pediatrics
Non-Pharmacological Pain Intervention for Pediatric Chronic Pancreatitis
NIH R01  •  5 years

Jason Wilken  •  Physical Therapy & Rehabilitation Science
Comparative Effect of Commercially Available Custom Dynamic Orthoses
US DOD  •  4 years

Other Awards

Ferhaan Ahmad  •  Internal Medicine
EXPLORER-HCM
MyoKardia, Inc.

Carryn Anderson  •  Radiation Oncology
Superoxide Dismutase Mimetic GC4419 to Reduce Severe Oral Mucositis
Galera Therapeutics, Inc.

David Elliott  •  Internal Medicine
Study in LHA-DQ2.5+ Adults with Celiac Disease to Assess the Effect of Nexvax 2 on Symptoms after Masked Gluten Food Challenge
ImmusanT, Inc.

Muhammad Furqan  •  Internal Medicine
CMP-001 in Combination with Atezolizumab with and without Radiation Therapy in Subjects with Advanced Non-Small Cell Lung Cancer
Checkmake Pharmaceuticals

Delwyn Miller  •  Psychiatry
T2 PROTECT AD
University of California, San Diego

Michael O'Donnell  •  Urology
Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder
Hoosier Cancer Research Network, Inc.

Antonio Sanchez  •  Internal Medicine
Rifaximin Soluble Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy
Salix Pharmaceuticals, Inc.

Margarida Silverman  •  Internal Medicine
Ruxolitinib vs. best available therapy in patients with corticosteroid-refractory chronic graft vs host disease after allogenic stem cell transplantation
Incyte Corporation

Lucy Wibbenmeyer  •  Surgery
Efficacy and safety of NexoBrid compared to Standard of Care treatment
MediWound, Inc.

 

SEPTEMBER 2018 

New Federal Awards

Joe Cullen & Doug Spitz  •  Surgery & Rad Onc
Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy 
NIH P01  •  5 years

Joseph Buckwalter  •  Orthopedics & Rehabilitation
Translating Metabolic Responses to Mechanical Insult into Early Interventions to Prevent PTOA
US Department of Defense

Paul McCray  •  Pediatrics
CRISPR Ribonucleoproteins to Airway Epithelia Using Novel Amphiphilic Peptides  
NIH UG3  •  3 years

Hai-Hai Xue  •  Microbiology
Ezh2 regulates follicular helper T cell differentiation 
NIH R01  •  5 years

Chris Adams  •  Internal Medicine
Novel signaling pathways underlying skeletal muscle atrophy
NIH R01  •  5 years

David Weiss  •  Microbiology
Peptidoglycan binding protein specificity and bacterial cell division 
NIH R01  •  4 years

Georgina Aldridge  •  Neurology
Cortical Mechanisms in Lewy Body Dementia 
NIH K08  •  5 years

Mitchell Coleman  •  Radiation Oncology
Do Changes in Thiol Metabolism Mediate Osteoarthritis Progression? 
NIH R00  •  3 years

Peg Nopoulos  •  Psychiatry
Transfusion of Prematurity Early School Age Follow-up (TOP 5) CCC  
NIH UG3  •  1 year

Jeffrey Segar  •  Pediatrics
Fenoldopam to prevent renal dysfunction in indomethacin treated preterm infants  
NIH R21  •  2 years

Sharon Idiga  •  Pharmacology
Endocrine Circuit Regulating Sugar Satiety 
NIH F31  •  2 years

Alexander Greiner  •  Internal Medicine
MSX1 in Cardiac Fibrosis and Sudden Death  
NIH F30  •  4 years

Competitive Renewals

David Stoltz  •  Internal Mediciner
Origins of Cystic Fibrosis Airway Disease  
NIH P01  •  5 years

Rob Cornell  •  Anatomy & Cell Biology
Dissecting the transcriptional network governing differentiation of periderm
NIH R56  •  1 year

Todd Washington  •  Biochemistry
Mechanisms of Damaged DNA Replication in Eukaryotes 
NIH R01  •  4 years

Clinical Trial Support

Steven Polyak  •  Internal Medicine
Upadacitinib (ABT-494) in Subjects with Crohn's Disease
AbbVie Inc.

Randy Loftus  •  Anesthesia
Reducing Perioperative S. aureus Transmission
Anesthesia Patient Safety Foundation

Mo Milhem  •  Internal Medicine
DSP-7888 Dosing in Combination with Immune Checkpoint Inhibitors in Adult Subjects with Advanced Solid Tumors
INC Research, LLC

Steven Lentz  •  Internal Medicine
Pathfinder 8
Novo Nordisk, Inc.

Kirill Nourski  •  Neurosurgery
Mechanisms of anesthetic-induced unconsciousness
University of Wisconsin-Madison

 

AUGUST 2018 

New Federal Awards

Enrique Leira  •  Neurology
UI Regional Stroke Research Network 
NIH U21  •  5 years

Robert Weiss  •  Internal Medicine
Injury in Calcific Aortic Valve Disease
NIH R01  •  4 years

Stephen Hillis  •  Radiology
Generalized Obuchowski-Rockette Methodology for Analysis of Radiologic Diagnostic Imaging
NIH R01  •  4 years

Michael Anderson  •  Physiology
Genetic modifiers of Cep290-mediated retinal degeneration  
NIH R21  •  2 years

Rudragouda Channappanavar  •  Microbiology
Interferon lambda in host protection during aging 
NIH R21  •  2 years

Ali Jabbari  •  Dermatology
Defining T helper cell associated cytokines and mechanisms in Alopecia Areata   
NIH K08  •  3 years

Competitive Renewals

Rob Cornell  •  Anatomy & Cell Biology
Regulation of the Melanocyte Lineage by the AP2 Transcription Factor Family
NIH R01  •  5 years

Rob Piper  •  Physiology
Ubiquitin-dependent sorting in endosomes and the TGN
NIH R01  •  4 years

Clinical Trial Support

Steven Polyak  •  Internal Medicine
Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn's Disease
AbbVie, Inc

Mark Santillan  •  Obstetrics & Gynecology
Mechanisms of Early and Late Postpartum Hypertension in Human Preeclampsia
American Heart Association

Huy Tran  •  Internal Medicine
Obeticholic Acid in Subjects with Cirrhosis
Intercept Pharmaceuticals, Inc.

Michael Ohl  •  Internal Medicine
Public Health-Partnered Tele-Medical Pre-Exposure Prophylaxis Delivery in a Rural State
Iowa Department of Public Health

Sneha Deepak Phadke  •  Internal Medicine
Alpelisib plus fulvestrant or letrozole in patients with PIK3CA
Novartis

Muhammad Furqan  •  Internal Medicine
First-Line Therapy in Patients with Metastatic NSCLC
Pharmaceutical Research Associates

 

JULY 2018 

New Federal Awards

Dan Weeks  •  Biochemistry
Amyloids, aggregates and nucleolar activity in Xenopus development
NIH R01  •  4 years

Frank Faraci  •  Internal Medicine
Central RAAS and Brain Small Vessel Disease
NIH R01  •  5 years

Robert Block  •  Anesthesia
General Anesthesia During Early Childhood and Brain Development 
NIH R01  •  5 years

Wendy Maury  •  Microbiology
Modeling Filovirus Infection of and Trafficking through Skin  
NIH R01  •  4 years

Catherine Musselman  •  Biochemistry
Molecular mechanisms of histone signaling in a chromatin relevant context  
NIH R35  •  5 years

Adam Dupuy  •  Anatomy & Cell Biology
The role germline polymorphisms on ALL susceptibility  
NIH R21  •  2 years

Bradley Erickson  •  Urology
Understanding the Role of Local & Systemic Inflammation in Male Urethral Stricture Disease  
NIH R21  •  2 years

Rebecca Dodd  •  Internal Medicine
Mechanisms of NF1+/- Myeloid Cell Function in MPNSTs
US Department of Defense

Loreen Herwaldt  •  Internal Medicine
SHEPheRD RFTOP 2018 Domain-1-A001
US Dept of HHS 

Laurie Gutmann, Harold Adams, Nandakumar Narayanan, Mike Shy, Katherine Matthews & Peggy Nopoulos  •  Neurology, Pediatrics & Psychiatry
University of Iowa's NeuroNEXT Clinical Research Site   
NIH U24  •  5 years

Competitive Renewals

John Harty  •  Microbiology
Understanding immune regulation in blood-stage malaria
NIH R01  •  4 years

Clinical Trial Support

Mony Fraer  •  Internal Medicine
OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy
Omeros Corporation

Mo Milhem  •  Internal Medicine
UV1 Vaccine in First-Line Malignant Melanoma Patients
Ultimovacs AS